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Abstract
Background
Accurate estimates of multiple breath washout (MBW) outcomes require correct operation of
the device, appropriate distraction of the subject to ensure they breathe in a manner represen-
tative of their relaxed tidal breathing pattern, and appropriate interpretation of the acquired
data. Based on available recommendations for an acceptableMBW test, we aimed to develop
a protocol to systematically evaluate MBWmeasurements based on these criteria.
Methods
50MBW test occasions were systematically reviewed for technical elements and whether the
breathing pattern was representative of relaxed tidal breathing by an experiencedMBWopera-
tor. The impact of qualitative and quantitative criteria on inter-observer agreement was assessed
across eight MBWoperators (n = 20 test occasions, compared using a Kappa statistic).
Results
Using qualitative criteria, 46/168 trials were rejected: 16.6% were technically unacceptable
and 10.7% were excluded due to inappropriate breathing pattern. Reviewer agreement was
good using qualitative criteria and further improved with quantitative criteria from (κ = 0.53–
0.83%) to (κ 0.73–0.97%), but at the cost of exclusion of further test occasions in this retro-
spective data analysis.
Conclusions
The application of the systematic review improved inter-observer agreement but did not
affect reported MBW outcomes.
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Introduction
The lung clearance index (LCI), derived from the multiple breath inert gas washout (MBW)
test, has been shown to be feasible across all ages and to detect early pathologic changes associ-
ated with obstructive lung disease.[1, 2] The availability of commercial MBW devices provides
an opportunity to use the LCI as an outcome measure in multi-center randomized control
trial, as well as for the routine assessment of patients in the clinical setting.[3, 4] While the
MBW test requires minimal cooperation of the subject and is relatively easy to perform, accu-
rate estimates of MBW outcomes rely on correct operation of the device, appropriate distrac-
tion of the subject to ensure they breathe in a manner representative of their relaxed tidal
breathing pattern, and appropriate interpretation of the acquired data.[5]
The 2013 European Respiratory Society/American Thoracic Society (ERS/ATS) consensus
statement for inert gas washout measurement provides general recommendations on test pro-
cedure and helps to standardize MBW devices and outcomes. The consensus statement out-
lines the criteria for a technically acceptable washout test and states that MBW outcomes are to
be reported as the average of three technically acceptable washout curves [5]. However, there is
little guidance on how to apply these criteria practically to MBW data prospectively at the time
of test or as part of a retrospective review. In addition, while it is widely accepted that a subject
should breathe in a stable pattern representative of tidal breathing [6, 7], the evaluation of
breathing pattern is largely subjective and may introduce bias when interpreting outcomes. In
this study we aimed to 1) develop a protocol, which systematically evaluates MBWmeasure-
ments for technical elements and stability of the breathing pattern, 2) explore quantitative cri-
teria as an additional way to make the protocol more objective, 3) compare inter-reviewer
agreement of MBW trials, and 4) assess whether application of the protocol reduces the vari-
ability of reported outcomes.
Methods
Study Population
A random number generator was used to select 50 test occasions from a previously published
cross-sectional study [8]; 25 healthy children and 25 children with CF between the ages of 6
and 18 years were selected. The original study was approved by the research ethics board
(REB) at the Hospital for Sick Children (HSC), Toronto, Canada (REB# 1000019945).
Informed written consent was obtained from the parents or guardians of healthy children and
children with CF, and written assent was obtained from subjects who were able to understand
the proposed research and what was expected of them as research participants.
MBWMeasurements
Participants performed multiple breath nitrogen washout (MBN2W) using the Exhalyzer D
1
washout device (EcoMedics AG, Duernten, Switzerland), and associated Spiroware software
(version 3.1.6) until the operator determined that three good trials were obtained or the subject
was unable to continue testing.
Systematic Evaluation of MBW Trials
The ATS/ERS consensus document [5] was used as a guide to develop a check list and detailed
step-wise approach to facilitate the review of each MBW trial (see OLS). All MBW attempts
within each test occasion were then evaluated using the check list by an experienced reviewer
(RJ). The experienced reviewer (RJ) was involved in the data acquisition from a sub-set of the
subjects; however data acquisition occurred more than 3 years before this secondary review
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and thus was unlikely to have affected the subsequent interpretation. Each trial was evaluated
for technical elements. Trials were deemed technically unacceptable if 1) the tracer gas did not
re-equilibrate between trials, 2) there was clear evidence of a leak or 3) the trial did not meet
end of test criteria (see Table 1 for further details). The remaining technically acceptable trials
were systematically reviewed for appropriate breathing pattern (Table 1, OLS). Technically
acceptable trials that did not have a breathing pattern representative of relaxed tidal breathing
were deemed unacceptable. The only clinical information available to reviewers was the sub-
jects’ age, height and weight.
Quantitative Criteria
Data from both healthy children and children with CF were used to develop a quantitative
quality control criterion. Variability of VT was first quantified by calculating the within-trial
coefficient of variation (CV) % of the exhaled VT using tabular breath by breath data generated
by the Spiroware software. Pre-phase breaths were not included in the calculation, nor were
small breaths (tidal volume<3mL/kg). We then used the distribution of the CV VT in accept-
able and unacceptable trials to determine a cut-off which distinguished between acceptable and
unacceptable data. Trials with values above the cut-off ( 20%) were deemed unacceptable.
Table 1. Summary of technical and qualitative criteria used to evaluate MBW tracings.
Criteria for a Technically Acceptable Test
ATS/ERS Consensus Statement Additional Criteria
No evidence of leak A sudden spike in N2 concentration during
inspirationPremature rise in N2 signal early in expirogram
where N2 should be zero, or a decrease in airway dead
space volumeA sudden step change in volume time trace or
a step-up in N2 concentration plotted versus turn over (TO).
Deviations in the N2, O2 or CO2 signals inconsistent with
the phase of the breath (inspiration/expiration).An
increase in concentration of N2 due to dilution of oxygen
without a corresponding increase in carbon dioxide.Loss
of decay or prolonged plateau in end-tidal concentration
of N2. Concentration of N2 does not return to zero on
inspiration.
End of test criteria not met Three consecutive breaths where the normalized end-tidal
concentration of N2 fell below 2.5%
All three breaths should be tidal breaths appropriate for
the subjects size*
Inadequate time between
trials
Sufficient interval between runs when using resident inert
gases to allow inert gas concentration to return to baseline
values
End-tidal concentration of N2 at start of first trial of test
session 77%Starting end-tidal concentration of N2 of
subsequent trials within 1.5% of baseline
Evaluation of Breathing Pattern
Pre-Phase: Tidal Volume (VT)
& End expiratory lung volume
(EELV)
Stable VT and EELV over the preceding 30 s prior to start
washout.No small volume breath immediately prior to start of
washout Deviation in EELV at start of washout within 10% of
mean VT of 5 breaths immediately preceding the start of
washout
Exhaled VT for the last 5 breaths of the pre-phase
appropriate for the subjects size*No sigh or very small
breath immediately preceding washout rejected. No
acute shift in volume/time trace over last 5 breaths of
pre-phase.
Washout: Tidal Volume (VT)&
End expiratory lung volume
(EELV)
EELV is stable during washout Stable volume drift is
acceptable; a sudden step change in volume time trace is
acceptable provided leak was ruled out
VT throughout the washout are appropriate for the
subjects size*Minor deviations from VT (i.e. swallow) are
acceptable
Flow No coughing Stable respiratory flow rate with passive expiratory phase
throughout the test.No evidence of forced exhalation;
minor deviations (i.e. short breath hold) acceptable.
Trapped Gas Release No evidence of significant trapped gas release with larger
breaths.
If sigh or large breath, there is no evidence of increase in
N2 signal over and above variability produced by tidal
breaths.
Respiratory rate No evidence of hyper or hypoventilation based on
progression of end-tidal carbon dioxide concentration
Repeatability of FRC FRC within 25% of the mean FRC of all technically
acceptable trials
*10–15ml/kg of 10th -90th % ideal body weight where ideal body weight was defined using the CDC pediatric growth charts [9]
doi:10.1371/journal.pone.0157523.t001
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We determined ideal tidal volume (10–15ml/kg) for each subject assuming an ideal body
weight for the subject’s age; ideal body weight was defined as 10th-90th weight-for-age percen-
tile using the CDC growth charts as a reference [9]. Thus the range of ideal tidal volume for
each subject was calculated as 10ml  weight at the 10th centile-for-age, and 15ml  weight at
the 90th centile-for-age. Finally, we calculated repeatability for FRC as recommended by the
ATS/ERS consensus statement, whereas for LCI we used the first acceptable trial as a bench
mark to calculate the relative difference in LCI for all subsequent trials.
Statistical Analysis
Inter-Reviewer Agreement. To assess the agreement between reviewers a sub-set of 20
test occasions were reviewed by 8 MBW operators from 4 institutions (MP, RF, KR, CS, PR,
MK, KH, and HW). Reviewers were asked to independently evaluate each tracing, identifying
trials that were technically acceptable with an appropriate breathing pattern using the qualita-
tive criteria described in Table 1 as well as the check list in S1 File. We compared inter-reviewer
agreement for the decision to accept/reject between the primary reviewer (RJ) and each of the 8
reviewers using the Kappa (κ) statistic.
Comparison of Outcomes. To evaluate whether the systematic quality control review
improved the precision of the LCI, we compared the within-test coefficient of variation (stan-
dard deviation/mean) and the inter-class correlation coefficient (ICC) of LCI from all trials to
those classified as acceptable after qualitative review by the primary reviewer (RJ) and after the
addition of the quantitative criteria. We also compared the average LCI calculated from all tri-
als to the average LCI calculated after qualitative and quantitative review using a paired t-test.
Statistical analyses were done using Stata 13.0 (StataCorp 2013).
Results
Study Population
Demographic characteristics of the study population are described in Table 2. The CF group was
slightly older and had elevated LCI compared to the healthy children. A total of 168 complete
MBW trials from the 50 test occasions (range of 2–7 trials per test occasion) were reviewed.
Systematic Evaluation of MBW Trials
Of the 168 trials, 28 (16.6%) were technically unacceptable and a further 18 (10.7%) trials were
found not to have a breathing pattern representative of a relaxed tidal breathing. Exclusion of
these 46 trials led to the exclusion of 16 (32%) test occasions; where a successful test occasion
required at least two acceptable trials. None of the 168 trials were outside the FRC exclusion lim-
its proposed by the ATS/ERS consensus document (>25% of the mean FRC value). LCI values
were more repeatable when acceptable trials were compared; 60% of acceptable trials were within
5% of the first, whereas this was only true for 6% of unacceptable trials. Eighty-five percent of all
acceptable trials were within 10% of the first, compared with 22% of unacceptable trials. Eighty-
eight percent of acceptable LCI trials were within 1 LCI unit of the first acceptable trial. Using
qualitative criteria alone the agreement between the primary reviewer and each of the eight exter-
nal reviewers was good (n = 61 trials from a sub-set of 20 test occasions (Table 3)). The kappa sta-
tistic was>60%, indicating strong agreement for the majority of results.[10]
Impact of additional Quantitative Criteria
There was a significant difference in tidal volume variability (% CV VT) between acceptable
and unacceptable trials (mean CV% 13.8 (SD 3.4) acceptable trials vs. 24.7 (SD 9.8) for
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unacceptable trials; non-parametric t-test p<0.001, Fig 1). The distribution of the VT for
acceptable trials (Range 7.0; 19.4) was used to define a cut-off of 20% as acceptable. When we
applied the 20 CV% VT cut-off to the dataset, an additional 25 trials and 10 test occasions were
excluded. When we independently applied the limits of an appropriate VT for subjects’ size to
the dataset an additional 6 trials and 1 test occasion were excluded. Repeatability of LCI was
similar when quantitative criteria were applied to define acceptable tests (data not shown). In
all instances, regardless of training and experience, the addition of a quantitative component
(either CV VT% or mean VT appropriate for size), improved the agreement between reviewers
(Table 3). The kappa statistic was>80%, indicating almost perfect agreement for the majority
of results.[10]
Table 2. Demographics of cross-sectional study population, with results from each step of the quality control criteria applied.
Total (n = 50) Healthy (n = 25) CF (n = 25) Δ CF- HC*
Age: mean (range) 14.2 (7.7, 17.8) 13.4 (7.7, 17.2) 15.1 (9.5, 17.8) 1.7 (0.2, 3.1)
Male subjects: n (%) 20 (40%) 11 (44%) 9 (36%) -8% (-35, 63%)
N trials (Median; Range acceptable trials) 168 (2; 1–5) 80 (2; 1–5) 88 (2; 1–4)
Trials excluded for technical reasons: n (%) 28 (17%) 11 (13%) 17 (21%) 8% (-3, 20%)
Trials excluded for breathing pattern after qualitative review: n (%) 18 (11%) 16 (18%) 2 (3%) -15% (-24, 7%)
Trials excluded for breathing pattern using CV VT >20%: n (%) 25 (15%) 14 (16%) 11 (14%) -2% (-13, 9%)
Trials excluded for breathing pattern using VT appropriate for size; n (%) 6 (3.6%) 2 (2.5%) 4 (4.5%) 2% (-7.5%, 3.5)
Trials not meeting 25% FRC criteria: n (%) 0 0 0 n/a
LCI (all n = 50): mean (SD) 9.9 (4.2) 6.8 (0.4) 13.0 (3.8) 6.2 (4.6, 7.7)
LCI (qualitative review n = 34): mean (SD) 10.2 (4.4) 6.9 (0.4) 13.5 (4.0) 6.6 (4.6, 8.6)
LCI (excluding CV VT >20%: n = 24): mean (SD) 10.1 (4.5) 6.8 (0.4) 13.4 (4.2) 6.7 (4.1, 9.2)
LCI (excluding VT not appropriate for size: n = 33): mean (SD) 10.2 (4.5) 6.9 (0.4) 13.8 (4.0) 6.9 (4.9, 8.9)
CF: Cystic Fibrosis
LCI: Lung Clearance Index
VT: Tidal volume
CV: Coefficient of Variation
SD: standard deviation
* bold values indicate results are statistically significant (p<0.05).
doi:10.1371/journal.pone.0157523.t002
Table 3. Inter-Reviewer Agreement after independent review of 20 test-occasions (61 trials). Quantitative limits were applied after qualitative review,
however each of the two quantitative limits (%CV VT and VT limits for size) were applied independently.
Agreement after Qualitative Review Agreement after %CV VT limits applied Agreement after appropriate VT limits
applied
Reviewer % Kappa Statistic (95% Confidence
Interval)
% Kappa Statistic (95% Confidence
Interval)
% Kappa Statistic (95% Confidence
Interval)
1 90% 0.75 (0.56, 0.94) 90% 0.80 (0.65, 0.95) 93% 0.87 (0.75, 0.99)
2 85% 0.59 (0.35, 0.83) 87% 0.73 (0.56, 0.91) 92% 0.84 (0.70, 0.97)
3 85% 0.53 (0.27, 0.79) 87% 0.73 (0.56, 0.91) 93% 0.87 (0.75, 0.99)
4 90% 0.75 (0.56, 0.94) 90% 0.80 (0.65, 0.95) 92% 0.84 (0.70, 0.97)
5 92% 0.77 (0.58, 0.96) 92% 0.83 (0.69, 0.97) 92% 0.83 (0.69, 0.97)
6 95% 0.74 (0.54, 0.93) 92% 0.84 (0.70, 0.97) 95% 0.90 (0.79, 1.00)
7 93% 0.81 (0.63, 0.99) 95% 0.90 (0.79, 1.00) 98% 0.97 (0.90, 1.00)
8 95% 0.83 (0.64, 1.00) 96% 0.93 (0.83, 1.00) 98% 0.97 (0.90, 1.00)
doi:10.1371/journal.pone.0157523.t003
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Comparison of Outcomes
Application of neither qualitative review nor quantitative criterion for breathing pattern stabil-
ity changed the interpretation of group differences between health and disease: The difference
in LCI between health and disease using all data was 6.2 (95% CI 4.6; 7.7, n = 50), compared
with 6.6 (4.6; 8.6, n = 34) after qualitative review (Table 2). Similar results were observed when
each of the two quantitative criterion for breathing pattern stability were applied (Table 2). The
average LCI calculated as the mean of all trials (LCI = 9.9 (SD = 4.2), n = 50) was similar to the
mean calculated from trials that were deemed acceptable after qualitative review (10.2
(SD = 4.4), n = 34) and when both quantitative criterion were applied (CVVT 10.1 (4.5) and VT
size 10.2(4.5)). In a sub-set of subjects that had acceptable and unacceptable trials within the
same test occasion, the exclusion of unacceptable changed the LCI between -0.2 units to 0.5
units. The within-subject within-test CV of the LCI for all trials was 5.1% (SD 4.4), and was
smaller after qualitative review 3.3% (SD 2.5), and after we applied each of the two quantitative
criterion (CV VT 4.2% (SD 2.6%), VT size 3.6% (SD 2.4)). There was no statistical difference
between the LCI if two acceptable trials were reported instead of three [n = 31, mean difference
0.04 (-0.04; 0.11), p = 0.3490]. The systematic evaluation of MBW trials marginally improved
the precision of the reported LCI values (ICC 98.6 vs. 95.0).
Discussion
In this study we used the ATS/ERS MBW consensus statement as a basis to further develop a
protocol to systematically evaluate MBW trials for technical criteria and appropriate breathing
pattern. The systematic evaluation of MBW trials did not affect the reported LCI value on a
group level, but it did change individual values. Overall there was good inter-review agreement
between multiple reviewers after qualitative review, which was improved with the addition of a
quantitative criterion for breathing stability. Systematic review of MBW trials could facilitate
Fig 1. Distribution of CV% VT for acceptable and unacceptable trials.
doi:10.1371/journal.pone.0157523.g001
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improved standardization between groups and consequently improve the reporting and inter-
pretation of MBW outcomes.
In addition to correct operation of the device and technical considerations of the MBW test,
accurate interpretation of results depends on the subject’s breathing pattern. The MBW test
aims to evaluate the evenness of gas mixing within the lungs during normal tidal breathing at
resting lung volume. Therefore it is essential that the subject breathes in their ‘normal’ manner
during the test. However, it may be unreasonable to expect subjects to breathe in a perfectly sta-
ble and repeatable breathing pattern during washout and some degree of irregularity must be
accepted. We sought to standardize the subjective review of breathing pattern, and developed a
threshold for acceptability based on CV VT. Application of this additional criterion led to
improved agreement between observers, albeit at the cost of feasibility. Conversely, excluding
trials where the tidal volume was not appropriate for size improved inter-reviewer agreement
and did not exclude many test occasions. Verbanck et al., used a fixed volume protocol to stan-
dardize tidal volume (and therefore breathing pattern) during MBW, whereby subjects were
instructed to breathe at a tidal volume of 1L.[11] While this protocol may stabilize breathing, it
is challenging in younger children, and the 1L target is not appropriate. Yammine et al., found
that the fixed 1L protocol did minimize the % CV VT, but that restricting paediatric subjects to
breathe at a fixed volume leads to statistical and clinical over-estimation of the LCI and changes
in the FRC [12]. In an attempt to add objective assessment of breathing pattern, we chose a dif-
ferent approach, which focused on the correct identification of those trials with a stable breath-
ing pattern. As this was a retrospective review of an existing dataset, where data were collected
before the ATS/ERS consensus statement was published, it may not reflect what would happen
in a prospective study. Quantitative limits for VT size and variability built into commercial soft-
ware may provide useful reminders to MBW operators and encourage them to collect addi-
tional during which the subject breathes within the suggested limits. In addition all of the
reviewers were experienced testers, familiar with respiratory physiology. It has yet to be deter-
mined whether the same would apply to less experienced MBW operators.
The ATS/ERS consensus statement includes broad recommendations for a technically
acceptable trial, including that any trial with an FRC greater than 25% different from the
median should be excluded. In this study, there were no test occasions where the FRC
was 25% of the median FRC. Reliance on the FRC criteria alone would have led to inclusion
of a significant proportion (16.6%) of trials in which the breathing pattern was deemed not
appropriate. LCI repeatability showed that acceptable MBW trials were more repeatable; how-
ever, just as is the case for spirometry, repeatability of an outcome should only be considered if
the test was technically sound. In our analysis, we did not see changes in the average LCI, sug-
gesting that LCI is a robust outcome for use in cross-sectional studies, whereas the differences
observed within an individual subject suggest that impact of test quality will be larger within
longitudinal studies or when treatment effects are measured using change in LCI.
The shape of the MBW curve is generated from a series of complex physiologic mechanisms
and technical components. Furthermore, multiple breathing events can occur within a single
MBW washout and each can influence the outcome independently; thus the impact on the LCI
is unpredictable. Several research studies report quality control steps for MBW data, including
identification of leaks, sighs and irregular breathing pattern; however specific details and quan-
titative limits are rarely included in the reports. The importance of signal alignment and soft-
ware settings has also recently been demonstrated, highlighting the importance of correct
operation of the equipment.[13] The overarching message from these available studies con-
firms that accurate interpretation of MBW outcomes requires a standardized protocol for the
operation and interpretation of MBW tests. This is particularly relevant for longitudinal stud-
ies, where the variability of the outcome within and between subjects will affect interpretation
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of the results. The proposed qualitative review and quantitative criterion for breathing pattern
stability need to be validated prospectively in a larger and longitudinal dataset.
Limitations
We developed a protocol to systematically evaluate MBW tracings based on available evidence
and tested it with knowledgeable MBW operators. Our findings are limited to a single dataset
of 50 test occasions collected many years ago at a center and thus require further validation in
other MBW outcomes, age groups, disease severities, disease groups, subject MBW testing
experience, and testing in interventional studies. Our findings are not directly transferrable to
other MBW set-ups (i.e. nitrogen washout by other manufactures or where SF6 is used as a
tracer gas).
Conclusions
As the MBW test moves from the research setting into clinical practice, there is a growing need
to standardize measurement protocols, as well as interpretation strategies using a similar for-
mat to what exists for other pulmonary function tests, such as spirometry. This study provides
a tool which can be used to further standardize reporting and interpretation of MBW
outcomes.
Supporting Information
S1 File. Detailed description of qualitative quality control check list with accompanying
worksheet.
(PDF)
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